Related Experiment Video
Updated: May 29, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
Recurrent aphthous ulcers--a Toll-like receptor-mediated disease?
Jarkko Hietanen1, Ritva Häyrinen-Immonen, Ahmed Al-Samadi
1Department of Oral Pathology, Institute of Dentistry, University of Helsinki, Helsinki, Finland.
Recurrent aphthous ulcer (RAU) is an autoinflammatory disorder. In RAU, the normally deep Toll-like receptor (TLR) defense zone extends to the surface, increasing reactivity to microbial triggers and causing painful ulcers.
Area of Science:
- Immunology
- Dermatology
- Oral Medicine
Background:
- Recurrent aphthous ulcer (RAU) presents as painful oral ulcerations with a tendency to recur.
- The exact cause of RAU remains unproven, with various pathogens proposed.
- RAU is hypothesized to be an autoinflammatory disorder triggered by microbial pathogen-associated molecular patterns (PAMPs).
Purpose of the Study:
- To investigate the role of PAMP-reactive Toll-like receptors (TLRs) in the oral epithelium of RAU patients compared to healthy controls.
- To determine if altered TLR expression or localization contributes to RAU pathogenesis.
Main Methods:
- Mapping of PAMP-reactive TLRs in the oral epithelium of healthy individuals and RAU patients.
- Comparative analysis of TLR distribution and expression levels between the two groups.
Main Results:
- Healthy oral epithelium exhibits a polarized TLR distribution, with a superficial non-reactive barrier and deeper reactive zones.
- RAU patients display a loss of TLR polarity, with TLRs found throughout the epithelium and increased expression of certain TLRs.
- RAU lesions show significant infiltration of TLR-expressing inflammatory cells in the connective tissue stroma.
Conclusions:
- The normal TLR organization in oral mucosa acts as a defense mechanism against microbes.
- In RAU, the TLR-reactive zone extends to the surface, becoming exposed to microbial PAMPs.
- Altered TLR organization and enhanced inflammatory cell recruitment in RAU suggest a TLR-mediated disease process.
More Related Videos
Related Concept Videos
Gastritis II: Pathophysiology
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Ulcerative Colitis
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Chronic Inflammation: Introduction

